Athena Technology Acquisition II, a blank check company targeting fintech, enterprise, and healthtech industries, raised $250 million by offering 25 million units at $10. Each unit consists of one share of common stock and one-half of a warrant, exercisable at $11.50.
Athena Technology Acquisition II is led by Chairman and CEO Isabelle Freidheim, co-founder and former Managing Partner of Castle VC (formerly Starwood VC), and founder and Chairman of two other SPACs (ATHN, ACAQ.U). She is joined by CFO Anna Apostolova, a private equity investor at 7RIDGE, and President and Director Kirthiga Reddy, co-founder of F7 Ventures and former Investment Partner at SoftBank Investment Advisers.
Athena Technology Acquisition intends to focus on identifying businesses in the fintech, enterprise, deep tech, and health-tech industries, but will not target those with speculative business plans or excessive leverage.
Athena Technology Acquisition II plans to list on the NYSE under the symbol ATEK.U. Citi acted as sole bookrunner on the deal.
